Extensive Approach to Atrial Fibrillation: Background and Future Perspectives
A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Electrophysiology and Cardiovascular Physiology".
Deadline for manuscript submissions: 31 May 2024
Special Issue Editors
Interests: mechanisms and pathophysiology of cardiac arrhythmias; clinical and epidemiological aspects of patients with arrhythmia; technological innovation (devices and mapping systems) for the improvement of safety and efficacy of the treatment of complex cardiac arrhythmias; optimization and research of alternative energy sources for the percutaneous treatment of cardiac arrhythmias; computational models of systemic and cerebral circulation in the course of arrhythmia; epidemiological aspects, risk stratification and innovative treatments of sudden death; statistical models of risk stratification
Interests: electrophysiology; arrhythmology; radiation risks
Special Issue Information
Dear Colleagues,
This Special Issue is focused on atrial fibrillation, aiming to assess the complex interactions between prevention, prognostic and metabolic markers and therapies of atrial fibrillation (AF) from a comprehensive point of view. AF management cannot be limited to stroke prevention by anticoagulants and rhythm/rate control by drugs and/or transcatheter ablation. Increasing evidence has demonstrated the importance of a more extensive management and international guidelines have highlighted the importance of comorbidities optimization and risk factors management to improve symptoms and to reduce AF burden and complications. The final goal is to slow disease progression or even, ideally, avoid AF. On top of well-known factors, new parameters such as alcohol consumption, physical activity, social stress, autonomic tone, adipose tissue, lipid profile, diabetes, obstructive sleep apnea, and genetics are emerging. In this Special Issue we are aiming to collect articles focusing on comprehensive approaches to AF. Moreover, we seek scientific works which transfer this knowledge in therapeutic actions, overcoming the standard electrophysiological management of AF.
Prof. Dr. Matteo Anselmino
Dr. Henri Xhakupi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atrial fibrillation
- omic approach
- metabolomics
- genomics
- risk factors
- prevention
- ablation
- stroke
- dementia
